| Ryan Telian, DPT | |
|
3 Springhurst Dr, East Greenbush, NY 12061-2261 | |
| (518) 479-7172 | |
| (518) 286-3798 |
| Full Name | Ryan Telian |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 3 Springhurst Dr, East Greenbush, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073277281 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 047799 (New York) | Primary |
| Provider Name | Columbia Physical Therapy Pc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1386724722 PECOS PAC ID: 6608780911 Enrollment ID: O20031119000295 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has immunized its first subject in a U.S. Phase I clinical trial to evaluate its SynCon™ H5N1 (avian) influenza DNA vaccine, VGX-3400X.
A study led by the UPV/EHU has developed an innovative, simple treatment based uterine stem cells to combat the Candida Albicans fungus, responsible for vaginal candidiasis disease.
DRG International, a leading international medical diagnostic company, will showcase the Newly Optimized DRG Saliva ELISA Assays at the 2016 AACC in Philadelphia, Pennsylvania from August 02-04.
A Korean study has recently demonstrated antiviral potency of monoclonal antibody CT-P59 against the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The experiments conducted in animals infected with the delta variant have shown that CT-P59 is able to reduce symptom intensity and viral replication in the respiratory tract. The study is currently available on the bioRxiv* preprint server.
› Verified 8 days ago
| Provider Name | Columbia Physical Therapy Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1386724722 PECOS PAC ID: 6608780911 Enrollment ID: O20040429000800 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has immunized its first subject in a U.S. Phase I clinical trial to evaluate its SynCon™ H5N1 (avian) influenza DNA vaccine, VGX-3400X.
A study led by the UPV/EHU has developed an innovative, simple treatment based uterine stem cells to combat the Candida Albicans fungus, responsible for vaginal candidiasis disease.
DRG International, a leading international medical diagnostic company, will showcase the Newly Optimized DRG Saliva ELISA Assays at the 2016 AACC in Philadelphia, Pennsylvania from August 02-04.
A Korean study has recently demonstrated antiviral potency of monoclonal antibody CT-P59 against the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The experiments conducted in animals infected with the delta variant have shown that CT-P59 is able to reduce symptom intensity and viral replication in the respiratory tract. The study is currently available on the bioRxiv* preprint server.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ryan Telian, DPT 3 Springhurst Dr, East Greenbush, NY 12061-2261 Ph: (518) 479-7172 | Ryan Telian, DPT 3 Springhurst Dr, East Greenbush, NY 12061-2261 Ph: (518) 479-7172 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has immunized its first subject in a U.S. Phase I clinical trial to evaluate its SynCon™ H5N1 (avian) influenza DNA vaccine, VGX-3400X.
A study led by the UPV/EHU has developed an innovative, simple treatment based uterine stem cells to combat the Candida Albicans fungus, responsible for vaginal candidiasis disease.
DRG International, a leading international medical diagnostic company, will showcase the Newly Optimized DRG Saliva ELISA Assays at the 2016 AACC in Philadelphia, Pennsylvania from August 02-04.
A Korean study has recently demonstrated antiviral potency of monoclonal antibody CT-P59 against the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The experiments conducted in animals infected with the delta variant have shown that CT-P59 is able to reduce symptom intensity and viral replication in the respiratory tract. The study is currently available on the bioRxiv* preprint server.
› Verified 8 days ago
Brooke Allen, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3 Springhurst Dr, East Greenbush, NY 12061 Phone: 518-479-7172 Fax: 518-286-3798 | |
Mrs. Doreen Frank, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3 Springhurst Dr, Suite 1, East Greenbush, NY 12061 Phone: 518-479-7172 Fax: 518-286-3798 | |
Prn Physical, Occupational And Speech Therapy Network, Pllc Physical Therapist Medicare: Medicare Enrolled Practice Location: 30 Community Way, East Greenbush, NY 12061 Phone: 518-410-6605 | |
Alison Romer, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3 Springhurst Dr, East Greenbush, NY 12061 Phone: 518-479-7172 Fax: 518-286-3798 | |
Columbia Physical Therapy Pc Physical Therapist Medicare: Medicare Enrolled Practice Location: 3 Springhurst Dr, Suite #1, East Greenbush, NY 12061 Phone: 518-479-7172 Fax: 518-286-3798 | |
Nicolla Physical Therapy Of East Greenbush Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 749 Columbia Tpke, East Greenbush, NY 12061 Phone: 518-479-2046 Fax: 518-477-5410 |